Pear Bio
Patient-centered Cancer Precision Medicine
Natick · Founded 2017
- Headquarters
- Natick, Massachusetts
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- pearbio.com
- Last Round
- Series AApr 2023
- Rounds
- 2
About
Pear Bio is a functional precision medicine company that develops personalized cancer treatment tests and novel therapeutics. The platform takes tumor biopsies from patients, converts them into 3D immune-microtumors, and tests multiple treatment options side-by-side to predict response and match patients with effective therapies. Excess tissue is characterized to identify new drug targets for cancers with high unmet need. Founded in 2017, Pear Bio serves both oncology drug discovery teams and individual cancer patients through its personalized testing services and computational biology platform.
Summary
Pear Bio is a company based in Natick, founded in 2017. Its most recent funding was a Series A round in Apr 2023. Investors include SOSV, octopus investments and Hoxton Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
